The review of this issue analysed oral antimuscarinics in adults suffering from neurogenic detrusor overactivity (NDO). Madersbacher et al. could include 30 studies (16 randomised controlled trials) enrolling 1479 patients. They conclude that antimuscarinics are effective in NDO, they normalize the intravesical pressure and increase cystometric bladder capacity. Contrary to idiopathic detrusor overactivity (IDO) no placebo effects manifested. Incidence rates of adverse events were comparable for NDO and IDO. Other important parameters, such as impact on the upper urinary tract function and morphology, continence, post void residual urine, catheterisation, urinary tract infections, and quality of life need to be studied better.
